Haleon Plc (HLN)
9.06
+0.19
(+2.14%)
USD |
NYSE |
Oct 07, 10:27
Haleon Market Cap : 39.75B for Oct. 7, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 06, 2026 | 38.91B |
| October 05, 2026 | 38.69B |
| October 02, 2026 | 38.60B |
| October 01, 2026 | 38.25B |
| September 30, 2026 | 39.48B |
| September 29, 2026 | 39.79B |
| September 28, 2026 | 40.23B |
| September 25, 2026 | 40.62B |
| September 24, 2026 | 40.45B |
| September 23, 2026 | 39.96B |
| September 22, 2026 | 40.58B |
| September 21, 2026 | 41.06B |
| September 18, 2026 | 40.71B |
| September 17, 2026 | 41.06B |
| September 16, 2026 | 40.40B |
| September 15, 2026 | 40.54B |
| September 14, 2026 | 41.19B |
| September 11, 2026 | 40.32B |
| September 10, 2026 | 40.45B |
| September 09, 2026 | 40.49B |
| September 08, 2026 | 40.58B |
| September 04, 2026 | 42.11B |
| September 03, 2026 | 43.26B |
| September 02, 2026 | 43.47B |
| September 01, 2026 | 44.18B |
| Date | Value |
|---|---|
| August 31, 2026 | 44.00B |
| August 28, 2026 | 44.35B |
| August 27, 2026 | 44.04B |
| August 26, 2026 | 44.62B |
| August 25, 2026 | 44.66B |
| August 24, 2026 | 44.57B |
| August 21, 2026 | 43.87B |
| August 20, 2026 | 43.30B |
| August 19, 2026 | 43.30B |
| August 18, 2026 | 42.64B |
| August 17, 2026 | 42.03B |
| August 14, 2026 | 42.55B |
| August 13, 2026 | 42.99B |
| August 12, 2026 | 42.99B |
| August 11, 2026 | 43.56B |
| August 10, 2026 | 43.56B |
| August 07, 2026 | 44.00B |
| August 06, 2026 | 44.00B |
| August 05, 2026 | 43.65B |
| August 04, 2026 | 42.90B |
| August 03, 2026 | 42.99B |
| July 31, 2026 | 43.30B |
| July 30, 2026 | 44.35B |
| July 29, 2026 | 45.10B |
| July 28, 2026 | 45.05B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AstraZeneca PLC | 496.89B |
| GSK Plc | 95.29B |
| Hikma Pharmaceuticals Plc | 4.468B |
| Allergy Therapeutics Plc | 921.22M |
| Shield Therapeutics Plc | 91.58M |
Market Cap Related Metrics
| PE Ratio | 18.63 |
| PS Ratio | 2.710 |
| PEG Ratio | 0.2936 |
| Price to Free Cash Flow | 15.42 |
| Price | 9.06 |
| Earnings Yield | 5.37% |
| PEGY Ratio | 0.2838 |
| Operating PE Ratio | 11.63 |
| Normalized PE Ratio | 16.93 |